Treatment Recommendations for Osteosarcoma and Adult Soft Tissue Sarcomas

Piero Picci, Stefano Ferrari, Gaetano Bacci, Franco Gherlinzoni

Research output: Contribution to journalArticle

Abstract

During the past 20 years, dramatic improvements have been obtained in the treatment of localised osteosarcoma of the extremities, both in the rates of disease-free survival and in quality of life. Twenty years ago 80 to 90% of the patients died, in spite of mutilating surgery, but now about 75% survive and avoid the necessity of amputation. This is due to the introduction of very effective combined treatments, mostly also using preoperative chemotherapy. One of the major issues is that of intensive preoperative chemotherapy, which improves both limb salvage and survival. A multidisciplinary approach is necessary to obtain good results. When the role of adjuvant or neoadjuvant chemotherapy is not accurately defined for soft tissue sarcomas, particular emphasis is given to the staging of the diseases and to the important role of local treatment in the survival of these patients. A combination of radiation therapy and surgery is strongly recommended.

Original languageEnglish
Pages (from-to)82-92
Number of pages11
JournalDrugs
Volume47
Issue number1
DOIs
Publication statusPublished - 1994

Fingerprint

Chemotherapy
Osteosarcoma
Sarcoma
Tissue
Drug Therapy
Surgery
Salvaging
Limb Salvage
Survival
Radiotherapy
Amputation
Disease-Free Survival
Therapeutics
Extremities
Quality of Life

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Treatment Recommendations for Osteosarcoma and Adult Soft Tissue Sarcomas. / Picci, Piero; Ferrari, Stefano; Bacci, Gaetano; Gherlinzoni, Franco.

In: Drugs, Vol. 47, No. 1, 1994, p. 82-92.

Research output: Contribution to journalArticle

Picci, P, Ferrari, S, Bacci, G & Gherlinzoni, F 1994, 'Treatment Recommendations for Osteosarcoma and Adult Soft Tissue Sarcomas', Drugs, vol. 47, no. 1, pp. 82-92. https://doi.org/10.2165/00003495-199447010-00006
Picci, Piero ; Ferrari, Stefano ; Bacci, Gaetano ; Gherlinzoni, Franco. / Treatment Recommendations for Osteosarcoma and Adult Soft Tissue Sarcomas. In: Drugs. 1994 ; Vol. 47, No. 1. pp. 82-92.
@article{d430cf25417c4049a329b6d7230ad6b4,
title = "Treatment Recommendations for Osteosarcoma and Adult Soft Tissue Sarcomas",
abstract = "During the past 20 years, dramatic improvements have been obtained in the treatment of localised osteosarcoma of the extremities, both in the rates of disease-free survival and in quality of life. Twenty years ago 80 to 90{\%} of the patients died, in spite of mutilating surgery, but now about 75{\%} survive and avoid the necessity of amputation. This is due to the introduction of very effective combined treatments, mostly also using preoperative chemotherapy. One of the major issues is that of intensive preoperative chemotherapy, which improves both limb salvage and survival. A multidisciplinary approach is necessary to obtain good results. When the role of adjuvant or neoadjuvant chemotherapy is not accurately defined for soft tissue sarcomas, particular emphasis is given to the staging of the diseases and to the important role of local treatment in the survival of these patients. A combination of radiation therapy and surgery is strongly recommended.",
author = "Piero Picci and Stefano Ferrari and Gaetano Bacci and Franco Gherlinzoni",
year = "1994",
doi = "10.2165/00003495-199447010-00006",
language = "English",
volume = "47",
pages = "82--92",
journal = "Drugs",
issn = "0012-6667",
publisher = "Adis International Ltd",
number = "1",

}

TY - JOUR

T1 - Treatment Recommendations for Osteosarcoma and Adult Soft Tissue Sarcomas

AU - Picci, Piero

AU - Ferrari, Stefano

AU - Bacci, Gaetano

AU - Gherlinzoni, Franco

PY - 1994

Y1 - 1994

N2 - During the past 20 years, dramatic improvements have been obtained in the treatment of localised osteosarcoma of the extremities, both in the rates of disease-free survival and in quality of life. Twenty years ago 80 to 90% of the patients died, in spite of mutilating surgery, but now about 75% survive and avoid the necessity of amputation. This is due to the introduction of very effective combined treatments, mostly also using preoperative chemotherapy. One of the major issues is that of intensive preoperative chemotherapy, which improves both limb salvage and survival. A multidisciplinary approach is necessary to obtain good results. When the role of adjuvant or neoadjuvant chemotherapy is not accurately defined for soft tissue sarcomas, particular emphasis is given to the staging of the diseases and to the important role of local treatment in the survival of these patients. A combination of radiation therapy and surgery is strongly recommended.

AB - During the past 20 years, dramatic improvements have been obtained in the treatment of localised osteosarcoma of the extremities, both in the rates of disease-free survival and in quality of life. Twenty years ago 80 to 90% of the patients died, in spite of mutilating surgery, but now about 75% survive and avoid the necessity of amputation. This is due to the introduction of very effective combined treatments, mostly also using preoperative chemotherapy. One of the major issues is that of intensive preoperative chemotherapy, which improves both limb salvage and survival. A multidisciplinary approach is necessary to obtain good results. When the role of adjuvant or neoadjuvant chemotherapy is not accurately defined for soft tissue sarcomas, particular emphasis is given to the staging of the diseases and to the important role of local treatment in the survival of these patients. A combination of radiation therapy and surgery is strongly recommended.

UR - http://www.scopus.com/inward/record.url?scp=0028008660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028008660&partnerID=8YFLogxK

U2 - 10.2165/00003495-199447010-00006

DO - 10.2165/00003495-199447010-00006

M3 - Article

C2 - 7510623

AN - SCOPUS:0028008660

VL - 47

SP - 82

EP - 92

JO - Drugs

JF - Drugs

SN - 0012-6667

IS - 1

ER -